So, pharmaceutical companies started investigating the use of GLP-1s for weight-management purposes, and the first GLP-1 weight-loss drug, Saxenda (liraglutide), was approved by FDA in 2014 (it was previously approved to treat diabetes under the name Victoza)
A number of device programs fail because they are too complex to integrate into existing and proven pharma processes. As an example, he points to primary drug containers
Graphical abstract Bu T, Sun Z, Pan Y, Deng X, Yuan G
But when done correctly, sublingual administration offers a needle-free alternative that many people prefer, and the results can be genuinely comparable when absorption is optimized
If you are unsure whether your medication is still good, checking semaglutide shelf life guidelines or tirzepatide shelf life information can help you make an informed decision
Answer : The major players in the GLP-1 market include Novo Nordisk, Eli Lilly and Company, Zealand Pharma, Structure Therapeutics, Amgen, Viking Therapeutics, Sanofi, AstraZeneca, and Hansoh Pharmaceutical Group Co